Table 2.
Age of surgery (years) | Age at FU2 (years) | Sex | Risk group | Diagnosis | Comorbidity | |
---|---|---|---|---|---|---|
Patient 1 | 1.1 | 14.1 | Female | HRG | SCM + TFT | – |
Patient 2 | 12.1 | 24.8 | Female | HRG | LMC + SCM + TFT | – |
Patient 3 | 1.1 | 13.8 | Female | HRG | LMC | Redo during FU |
Patient 4 | 6.8 | 19.5 | Female | Redo | LMC + TFT | – |
Patient 5 | 1.0 | 16.4 | Female | HRG | SCM + TFT + dermoid sinus | Intramedullary cyst |
Patient 6 | 3.6 | 18.3 | Female | HRG | LMC + TFT | Syringomyelia |
Patient 7 | 1.0 | 13.6 | Female | HRG | LMC | Syringomyelia |
Patient 8 | 6.1 | 17.2 | Female | HRG | SCM + TFT | – |
Patient 9 | 6.7 | 14.6 | Female | LRG | TFT | Intramedullary cyst |
Patient 10 | 11.3 | 20.1 | Female | LRG | MMC | – |
Patient 11 | 0.1 | 9.2 | Male | LRG | MMC | Syringomyelia + intramedullary cyst |
Mean (SD) | 4.6 (4.3) | 16.5 (4.2) | ||||
% | 91% female | 73% HRG |
HRG high-risk group, LRG low-risk group, Redo redetethering group, FU follow-up, SCM split cord malformation, TFT tight filum terminale, LMC lypomyelomeningocele, SD standard deviation